These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antioxidant enzymes and lipoperoxide in blood in patients with Kawasaki disease. Comparison with the changes in acute infections. Uchida N; Asayama K; Dobashi K; Hayashibe H; Kato K Acta Paediatr Jpn; 1990 Jun; 32(3):242-8. PubMed ID: 2239296 [TBL] [Abstract][Full Text] [Related]
3. Increased circulating granulocyte colony-stimulating factor in acute Kawasaki disease. Inoue Y; Kato M; Kobayashi T; Shinohara M; Sone K; Morikawa A Pediatr Int; 1999 Jun; 41(3):330-3. PubMed ID: 10365591 [No Abstract] [Full Text] [Related]
4. Spontaneous tumor necrosis factor production in Kawasaki disease. Lang BA; Silverman ED; Laxer RM; Lau AS J Pediatr; 1989 Dec; 115(6):939-43. PubMed ID: 2585231 [TBL] [Abstract][Full Text] [Related]
5. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease. Cabana VG; Gidding SS; Getz GS; Chapman J; Shulman ST Pediatr Res; 1997 Nov; 42(5):651-5. PubMed ID: 9357939 [TBL] [Abstract][Full Text] [Related]
6. Increased plasma lipid peroxidation in riboflavin-deficient, malaria-infected children. Das BS; Thurnham DI; Patnaik JK; Das DB; Satpathy R; Bose TK Am J Clin Nutr; 1990 May; 51(5):859-63. PubMed ID: 2185624 [TBL] [Abstract][Full Text] [Related]
7. Evidence for increased oxidative damage in patients with cystic fibrosis. Brown RK; Kelly FJ Pediatr Res; 1994 Oct; 36(4):487-93. PubMed ID: 7816524 [TBL] [Abstract][Full Text] [Related]